The canton of Basel-Stadt accounts for 26 percent of Swiss exports. The pharma and chemical industries have above all contributed to this result. In per capita terms, Basel-Stadt exports goods totaling 316,855 Swiss francs. In the BaselArea as a whole, which includes Basel-Landschaft and Jura, the equivalent figure stands at 148,811 Swiss francs per capita.Read More
Setting up a business in the Basel Area is a straight-forward process. The local authorities and Swiss government value your contribution to the business environment, and have a number of resources in place to help you. These include easy portals where you can register for business administration requirements, and taxes. Basel Area Business & Innovation will support you through the entire process by providing information, helping you find office space, and connecting you with experts like tax advisors, lawyers or recruiters.
Doing business in Switzerland
The Basel Area is Switzerland’s most innovative economic region, with the ideal mix of hard and soft location factors for global, European and Swiss headquarters.
Find an office/real estate
You’ll find a wide choice of real estate options in the Basel Area – from large development plots to production and warehousing facilities, right through to office space, technology/innovation parks and co-working spaces, as well as units suitable for light industrial and laboratory purposes.
Sitting on the borders with France and Germany will make it easy for your business to attract talent from all three countries as well as across Europe.
Once you’re settled in, you’ll find it easy to grow your network and expand your business connections through the many events we offer. Our unique event platform promotes regular exchanges of experiences and knowledge across firms and disciplines in the Basel Area.
Six steps to setting up your office
Whether you're relocating your headquarters, setting up a new marketing and sales division, or opening a research and development facility, it's never been easier to get your team on the ground in the Basel Area.Learn more
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More